Trial intelligence / Profile preview

Autologous conditioned serum dressing for chronic diabetic ulcers

IRCT20100720004422N7Phase 3Completed

Sponsor
Tabriz University of Medical Sciences
Start
Aug 2019
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of autologous conditioned serum in chronic ulcer and diabetic foot ulcer (DFU) (2 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoint: Ulcer size. Started Aug 2019; status: completed.

02

Drugs

autologous conditioned serum
03

Conditions

chronic ulcerdiabetic foot ulcer (DFU)

Beyond the preview

Go deeper on IRCT20100720004422N7.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20100720004422N7.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call